PDS-2
Commercial- Indications
- Homozygous familial hypercholesterolemia, Atherosclerosis
Company intelligence / Profile preview
HDL Therapeutics
Vero Beach, Florida, USAhdltherapeutics.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
HDL Therapeutics has developed and commercialized the PDS‑2 System, an FDA-approved therapeutic device that uses patients’ own plasma to generate pre‑β HDL. This system is indicated for reducing coronary atheroma in patients with homozygous familial hypercholesterolemia. Clinical results show significant regression of high-risk plaques in these patients; the therapy can be used alongside other lipid-lowering agents.
- Therapeutic areas
- OtherCardiovascular
- Modalities
- DeviceBiologic (via plasma delipidation and HDL manipulation)
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
1 asset03
Partnerships
Swiftmerge Acquisition Corp. – SPAC partner for going publicNo major pharma partnerships disclosed as of June 2025.
Beyond the preview
Go deeper on HDL Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HDL Therapeutics.